What are the Mechanisms of Resistance to Platinum-Based Drugs?
Cancer cells can develop resistance to platinum-based drugs through various mechanisms. These include increased DNA repair capabilities, reduced drug uptake, increased drug efflux, and detoxification of the drug through binding with sulfur-containing compounds like glutathione. Understanding these mechanisms is critical for developing strategies to overcome resistance and improve treatment outcomes.
